Correlation Between Syros Pharmaceuticals and Iovance Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Syros Pharmaceuticals and Iovance Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syros Pharmaceuticals and Iovance Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syros Pharmaceuticals and Iovance Biotherapeutics, you can compare the effects of market volatilities on Syros Pharmaceuticals and Iovance Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syros Pharmaceuticals with a short position of Iovance Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syros Pharmaceuticals and Iovance Biotherapeutics.
Diversification Opportunities for Syros Pharmaceuticals and Iovance Biotherapeutics
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Syros and Iovance is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Syros Pharmaceuticals and Iovance Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iovance Biotherapeutics and Syros Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syros Pharmaceuticals are associated (or correlated) with Iovance Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iovance Biotherapeutics has no effect on the direction of Syros Pharmaceuticals i.e., Syros Pharmaceuticals and Iovance Biotherapeutics go up and down completely randomly.
Pair Corralation between Syros Pharmaceuticals and Iovance Biotherapeutics
Given the investment horizon of 90 days Syros Pharmaceuticals is expected to under-perform the Iovance Biotherapeutics. In addition to that, Syros Pharmaceuticals is 4.38 times more volatile than Iovance Biotherapeutics. It trades about -0.17 of its total potential returns per unit of risk. Iovance Biotherapeutics is currently generating about -0.09 per unit of volatility. If you would invest 1,081 in Iovance Biotherapeutics on August 30, 2024 and sell it today you would lose (141.00) from holding Iovance Biotherapeutics or give up 13.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Syros Pharmaceuticals vs. Iovance Biotherapeutics
Performance |
| Timeline |
| Syros Pharmaceuticals |
| Iovance Biotherapeutics |
Syros Pharmaceuticals and Iovance Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Syros Pharmaceuticals and Iovance Biotherapeutics
The main advantage of trading using opposite Syros Pharmaceuticals and Iovance Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syros Pharmaceuticals position performs unexpectedly, Iovance Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iovance Biotherapeutics will offset losses from the drop in Iovance Biotherapeutics' long position.| Syros Pharmaceuticals vs. Surrozen | Syros Pharmaceuticals vs. Bolt Biotherapeutics | Syros Pharmaceuticals vs. Larimar Therapeutics | Syros Pharmaceuticals vs. Keros Therapeutics |
| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |